# Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection

> **NCT07116044** · — · COMPLETED · sponsor: **University of Molise** · enrollment: 160 (actual)

## Conditions studied

- Evaluate Response to Treatment Both Biochemically and Virologically to Determine the Safety and Effectiveness of Bulevirtide Therapy in HDV Patients

## Interventions

- **DIAGNOSTIC_TEST:** virological tests diagnostic tests

## Key facts

- **NCT ID:** NCT07116044
- **Lead sponsor:** University of Molise
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-15
- **Primary completion:** 2024-06-01
- **Final completion:** 2025-07-30
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116044, "Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07116044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*